<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The purpose of the present study was to determine whether using an extended panel of laboratory tests increases the detection of a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> in patients with ocular thromboses </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty consecutive patients with ocular thromboses (vein, artery, or choriocapillaris occlusions) underwent testing for activated protein C resistance/factor V Leiden, prothrombin G20210A, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin antibodies, <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e>, and deficiencies of protein C, protein S, and antithrombin </plain></SENT>
<SENT sid="2" pm="."><plain>For each patient, we selected two age-matched and gender-matched individuals without ocular thromboses as controls </plain></SENT>
<SENT sid="3" pm="."><plain>Sixteen of the 20 patients (80%) had one or more laboratory tests that supported a hypercoagulable condition </plain></SENT>
<SENT sid="4" pm="."><plain>Prothrombin G20210A (P &lt; 0.02) and <z:e sem="disease" ids="C0598608" disease_type="Disease or Syndrome" abbrv="">hyperhomocysteinemia</z:e> (P &lt; 0.0006) were significantly more frequent in ocular <z:mp ids='MP_0005048'>thrombosis</z:mp> patients compared with controls </plain></SENT>
<SENT sid="5" pm="."><plain>The most common condition was <z:hpo ids='HP_0003613'>antiphospholipid antibody</z:hpo> syndrome, present in 40% of patients (confirmed by repeat testing at least 6 weeks later), but this did not reach statistical significance compared with the controls </plain></SENT>
<SENT sid="6" pm="."><plain>No patients with ocular thromboses had hereditary abnormalities of protein S, protein C, or antithrombin </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, an extended panel of laboratory tests improved the detection of a <z:e sem="disease" ids="C0398623" disease_type="Disease or Syndrome" abbrv="">hypercoagulable state</z:e> in ocular thromboses </plain></SENT>
<SENT sid="8" pm="."><plain>Testing for <z:chebi fb="0" ids="17230">homocysteine</z:chebi>, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, and the prothrombin G20210A mutation should be considered in patients with ocular thromboses </plain></SENT>
</text></document>